GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OTCPK:ORXOY) » Definitions » Total Long-Term Assets

ORXOY (Orexo AB) Total Long-Term Assets : $17.09 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Orexo AB Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Orexo AB's Total Long-Term Assets for the quarter that ended in Mar. 2025 was $17.09 Mil.

Orexo AB Total Long-Term Assets Historical Data

The historical data trend for Orexo AB's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Total Long-Term Assets Chart

Orexo AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.98 44.91 35.99 31.95 13.51

Orexo AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.44 29.27 27.63 13.51 17.09

Orexo AB Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Orexo AB Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Orexo AB's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Orexo AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OTCPK:ORXOY) » Definitions » Total Long-Term Assets
Comparable Companies
OSTO:CINPHA OSTO:MOB OSTO:DICOT OSTO:NANEXA OSTO:ERMA OSTO:KLAR XSAT:ACUC OSTO:ENZY OSTO:VIVE OSTO:TOL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
ORX:Sweden 0H19:UK C5G:Germany
Address
Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105
Website
https://www.orexo.com
Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.